Literature DB >> 4252305

[Tryptophan metabolism in patients with pellagra].

G G Brune, R M Brune, A Wiskemann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4252305

Source DB:  PubMed          Journal:  Arch Dermatol Forsch        ISSN: 0003-9187


× No keyword cloud information.
  20 in total

1.  Identification and assay of urinary tryptamine: application as an index of monoamine oxidase inhibition in man.

Authors:  A SJOERDSMA; J A OATES; P ZALTZMAN; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1959-07       Impact factor: 4.030

2.  [METABOLIC DISORDERS IN POLYMORPHIC LIGHT DERMATOSES AND RECENT RESULTS OF INVESTIGATIONS IN CONNECTION WITH THE HARTNUP SYNDROME].

Authors:  J KIMMIG
Journal:  Arch Klin Exp Dermatol       Date:  1964-06-25

3.  A bufotenin-like substance in the urine of schizophrenics.

Authors:  E FISCHER; T A FERNANDEZ LAGRAVERE; A J VAZQUEZ; A O DI STEFANO
Journal:  J Nerv Ment Dis       Date:  1961-11       Impact factor: 2.254

4.  Correlations between behavior and urinary excretion of indole amines and catecholamines in schizophrenic patients as affected by drugs.

Authors:  G G BRUNE; G R PSCHEIDT
Journal:  Fed Proc       Date:  1961-12

5.  Leucine and pellagra.

Authors:  C GOPALAN; S G SRIKANTIA
Journal:  Lancet       Date:  1960-04-30       Impact factor: 79.321

6.  Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases.

Authors:  J M PRICE; R R BROWN; H A PETERS
Journal:  Neurology       Date:  1959-07       Impact factor: 9.910

7.  The determination in urine of some metabolites of tryptophankynurenine, anthranilic acid and 3-hydroxyanthranilic acid- and reference to the presence of o-aminophenol in urine.

Authors:  S L TOMPSETT
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

8.  The metabolic disorder in Hartnup disease.

Authors:  M D MILNE; M A CRAWFORD; C B GIRAO; L W LOUGHRIDGE
Journal:  Q J Med       Date:  1960-07

9.  Dimethyltryptamine experiments with psychotics.

Authors:  Z BOSZORMENYI; S SZARA
Journal:  J Ment Sci       Date:  1958-04

10.  OBSERVATIONS ON THE NATURE AND PROPERTIES OF THE FLUORESCENT FACTOR F2.

Authors:  V A Najjar; D B Scott; L E Holt
Journal:  Science       Date:  1943-06-11       Impact factor: 47.728

View more
  1 in total

1.  [Tryptophan-load in progressive scleroderma (author's transl)].

Authors:  H W Kreysel; K Meyerhoff; J Kimmig
Journal:  Klin Wochenschr       Date:  1976-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.